Filing Details
Nuo Therapeutics, Inc. (OTC:AURX) filed a Form 8-K with the Securities and Exchange Commission on August 17, 2026, disclosing a material event.
8k filedOTC:AURX
Nuo Therapeutics, Inc. (AURX) Reports Material Event to SEC
Nuo Therapeutics, Inc. (OTC:AURX) filed a Form 8-K with the Securities and Exchange Commission on August 17, 2026, disclosing a material event.
At publication ·
What changed
Nuo Therapeutics, Inc. (OTC:AURX) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Nuo Therapeutics, Inc. (AURX) filed a Form 8-K with the SEC on August 17, 2026, disclosing a material event that shareholders should be aware of, though the specific nature of the event is not detailed in this filing summary.
- The company's stock trades at $1.00 per share with a market capitalization of $101.0 million as a healthcare company.
Market Context
Nuo Therapeutics, Inc.'s stock currently trades at $1.00 with a market capitalization of $101.0M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Nuo Therapeutics, Inc.'s stock.
All SEC filings for Nuo Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View AURX Stock Page
Frequently Asked Questions
Where can I read AURX's SEC filings?
Browse all filings on our AURX SEC filings page.
What types of SEC filings does Nuo Therapeutics, Inc. file?
Public companies like Nuo Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
